News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

QuantRx Biomedical Corporation Announces MOU Agreement With Jant Pharmacal



3/5/2008 9:39:18 AM

DOYLESTOWN, PA--(Marketwire - March 05, 2008) - QuantRx® Biomedical Corporation (OTCBB: QTXB), a broad-based diagnostics company focused on the development and commercialization of innovative diagnostic products based on its patented technology platforms for the worldwide healthcare industry, today announced that it has entered into a Memorandum of Understanding agreement with Jant Pharmacal to form a strategic alliance to develop and commercialize new technologies and products in the areas of diagnostics and monitoring.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES